CRISPR Therapeutics AG - Common Shares (CRSP)
Seasonality Analysis
CRISPR Therapeutics AG - Common Shares Annual Seasonality Statistics
CRISPR Therapeutics AG - Common Shares Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 2.94% | Weak | |
| February | 9.70% | Strong | |
| March WORST | -9.83% | Very Weak | |
| April | 3.19% | Strong | |
| May | 9.41% | Weak | |
| June | 10.94% | Strong | |
| July | 2.68% | Strong | |
| August | -1.63% | Weak | |
| September | -5.32% | Very Weak | |
| October | 0.81% | Weak | |
| November BEST | 14.90% | Very Strong | |
| December | -5.86% | Weak |
CRISPR Therapeutics AG - Common Shares 2026 vs Historical Pattern
CRISPR Therapeutics AG - Common Shares Interactive Seasonality Chart
CRISPR Therapeutics AG - Common Shares Pattern Scanner
CRISPR Therapeutics AG - Common Shares Seasonal Historical Performance
About CRISPR Therapeutics AG - Common Shares (CRSP) Seasonality
CRISPR Therapeutics AG - Common Shares (CRSP) has been analyzed using 10 years of historical data to identify seasonal patterns. Classified under Stocks, CRISPR Therapeutics AG - Common Shares shows distinct seasonal tendencies based on historical data.
The strongest month for CRISPR Therapeutics AG - Common Shares is historically November, with an average return of 14.90% and a win rate of 80%. Conversely, March tends to be the weakest month, averaging -9.83% return.
Looking at the full calendar year, CRISPR Therapeutics AG - Common Shares has an average annual return of 31.94% with an overall monthly win rate of 53.0%. Out of 12 months, 8 typically show positive average returns.
The seasonal pattern for CRISPR Therapeutics AG - Common Shares has a consistency score of 56.3 (Fair), based on 11 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
CRISPR Therapeutics AG - Common Shares Seasonality FAQ
What is the best month to buy CRISPR Therapeutics AG - Common Shares (CRSP)?
Historically, November has been the best month for CRISPR Therapeutics AG - Common Shares, with an average return of 14.90% and a win rate of 80%. However, past performance does not guarantee future results.
What is the worst month for CRISPR Therapeutics AG - Common Shares (CRSP)?
Based on historical data, March has been the weakest month for CRISPR Therapeutics AG - Common Shares, with an average return of -9.83%. This is a historical observation and does not guarantee future results.
How reliable is CRSP seasonality data?
The seasonality analysis for CRISPR Therapeutics AG - Common Shares is based on 10 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use CRISPR Therapeutics AG - Common Shares seasonality in my trading?
Use CRISPR Therapeutics AG - Common Shares (CRSP) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.